Align Technology | ALGN - Aktuelle Verpflichtungen

Aktienkurs
189.59
Täglich Wechseln
-1.08 -0.57%
Monatlich
5.17%
Jährlich
3.40%
Q2 Prognose
185.89




Aktuelle Verpflichtungen Veränderung Datum
3M USD 9.03B 563M 2026-03
Align Technology USD 1.92B 46.45M 2025-12
Becton, Dickinson and Co. USD 8.76B 448M 2025-12
Bruker USD 1.28B 11.1M 2025-12
Cardinal Health USD 43.31B 3.05B 2025-12
Charles River Laboratories USD 1.12B 1.57M 2025-12
Cooper Companies USD 1.6B 482.9M 2025-12
CVS Health USD 88.69B 4B 2025-12
Danaher USD 7.46B 653M 2026-03
Dentsply International USD 1.34B 62M 2025-12
Dexcom USD 2.14B 1.19B 2025-12
Henry Schein USD 3.23B 79M 2025-12
Idexx Laboratories USD 1.15B 103M 2025-12
Insulet USD 680.1M 32.4M 2025-12
Integra LifeSciences USD 455.98M 91.93M 2025-12
IQVIA Holdings USD 8.34B 170M 2025-12
Masimo USD 371.6M 1.9M 2025-12
McKesson USD 68.13B 100M 2025-12
Mettler Toledo International USD 1.2B 5.99M 2025-12
Revvity USD 1.33B 108.5M 2025-12
Solventum Corp USD 3.14B 198M 2025-12
Stryker USD 7.79B 380M 2025-12
Teleflex USD 762.03M 11.01M 2025-12
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Veeva Systems USD 1.64B 692.18M 2025-12
Waters USD 1.24B 11.8M 2025-12
Zimmer Biomet Holdings USD 2.58B 180.8M 2025-12
Zoetis USD 2.24B 428M 2025-12